Letters

Now on Twitter: Follow the N&O editorial department at @NOopinionshop

Published Sat, May 21, 2011 02:00 AM
Modified Fri, May 20, 2011 11:39 PM

Hospital questions

Email Print Order Reprint
Share This
Text

tool name

close x
tool goes here
Tags: news | opinion - mailbag

Regarding the May 19 article "Hospital rivals go to the mat": This continuing Raleigh medical antagonism is intriguing, especially in view of the article in the May 18 Journal of the American Medical Association elucidating "Factors Associated with ER Closings" in urban hospital-based emergency departments. The chief driver seems to be the high cost of uncompensated care to the hospital system's bottom line, a fact that WakeMed's Bill Atkinson has not been reticent to publicly point out on numerous occasions.

There has historically been a town-gown schism between the inside the Beltline blueblood Rex and the outside the Beltline blue-collar Wake Memorial (now WakeMed), which apparently continues in that Atkinson points to the fact that Rex has not met its community obligation to take on its fair share of indigent uncompensated care.

It begs two questions: Is Wake's bid to purchase Rex then really a solution to this financial health care delivery quandary? And as the revolution in health care provision continues, is this not simply the next step toward a single-payer system?

C. Franklin Church, M.D., Raleigh

Get the biggest news in your email or cellphone as it's happening. Sign up for breaking news alerts.

Email Print Order Reprint
Share This
Text

tool name

close x
tool goes here
More Letters

Get editorial updates

Keep up with the latest opinions from the News & Observer, delivered straight to your inbox, for free!

- it's free!

Hot Deals View All
Find a Car
Go
Top Jobs View All

Find a Job
Go
Featured Homes View All
Find a Home
Go

Print Ads

 
We welcome your comments on this story, but please be civil. Do not use profanity, hate speech, threats, personal abuse, images, internet links or any device to draw undue attention. Read our full comment policy.